Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters)
- PMID: 38434665
- PMCID: PMC10905028
- DOI: 10.12688/f1000research.131230.2
Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters)
Abstract
Healthcare cost-effectiveness analysis is increasingly used to inform priority-setting in low- and middle-income countries and by global health donors. As part of such analyses, cost-effectiveness thresholds are commonly used to determine what is, or is not, cost-effective. Recent years have seen a shift in best practice from a rule-of-thumb 1x or 3x per capita GDP threshold towards using thresholds that, in theory, reflect the opportunity cost of new investments within a given country. In this paper, we observe that international donors face both different resource constraints and opportunity costs compared to national decision-makers. Hence, their perspective on cost-effectiveness thresholds must be different. We discuss the potential implications of distinguishing between national and donor thresholds and outline broad options for how to approach setting a donor-perspective threshold. Further work is needed to clarify healthcare cost-effectiveness threshold theory in the context of international aid and to develop practical policy frameworks for implementation.
Keywords: Global health; aid; cost-effectiveness; health financing; priority-setting; threshold.
Copyright: © 2024 Drake T et al.
Conflict of interest statement
No competing interests were disclosed.
Figures
Similar articles
-
The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review.Value Health. 2022 Mar;25(3):385-389. doi: 10.1016/j.jval.2021.08.014. Epub 2021 Oct 29. Value Health. 2022. PMID: 35227450 Free PMC article. Review.
-
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.Value Health. 2016 Dec;19(8):929-935. doi: 10.1016/j.jval.2016.02.017. Value Health. 2016. PMID: 27987642 Free PMC article.
-
Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.Lancet Glob Health. 2023 Jun;11(6):e833-e842. doi: 10.1016/S2214-109X(23)00162-6. Lancet Glob Health. 2023. PMID: 37202020
-
Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds.Health Policy Plan. 2017 Feb;32(1):141-145. doi: 10.1093/heapol/czw096. Epub 2016 Jul 24. Health Policy Plan. 2017. PMID: 27452949
-
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy.Appl Health Econ Health Policy. 2022 Sep;20(5):651-667. doi: 10.1007/s40258-022-00730-3. Epub 2022 Jun 7. Appl Health Econ Health Policy. 2022. PMID: 35668345 Free PMC article. Review.
References
-
- World Health Assembly 67: Sixty-seventh World Health Assembly, Geneva, 19-24 May 2014: resolutions and decisions: annexes. World Health Organization;2014 [cited 2022 Dec 21]. Report No.: WHA67/2014/REC/1. Reference Source
-
- Micah AE, Cogswell IE, Cunningham B, et al. : Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. Lancet. 2021 Oct 9;398(10308):1317–1343. 10.1016/S0140-6736(21)01258-7 - DOI - PMC - PubMed
-
- OECD Statistics:[cited 2023 Jan 26]. Reference Source
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials